165 related articles for article (PubMed ID: 8774650)
21. Detection of human papillomavirus types 16 and 18 in primary and in metastatic lesions of cervical carcinomas.
Mvula M; Iwasaka T; Matsuo N; Nakao Y; Kaku T; Hachisuga T; Fukuda K; Tsukamoto N; Sugimori H
Gynecol Oncol; 1994 May; 53(2):156-60. PubMed ID: 8188074
[TBL] [Abstract][Full Text] [Related]
22. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients.
Lentz SE; Muderspach LI; Felix JC; Ye W; Groshen S; Amezcua CA
Obstet Gynecol; 2004 Jun; 103(6):1204-10. PubMed ID: 15172853
[TBL] [Abstract][Full Text] [Related]
23. Can recurrence of cervical cancer be predicted by human papillomavirus DNA in nodes or plasma?
Peedicayil A; Sathish N; Gnanamony M; John S; Viswanathan FR; Naseema PS; Abraham P
J Low Genit Tract Dis; 2009 Apr; 13(2):102-6. PubMed ID: 19387130
[TBL] [Abstract][Full Text] [Related]
24. Increase of proliferating cell nuclear antigen (PCNA) expression in HPV-18 positive oral squamous cell carcinomas.
González-Moles MA; Rodríguez-Archilla A; Ruiz-Avila I; González-Moles S; Marfil-Alvarez R
Acta Stomatol Belg; 1996 Sep; 93(3):113-8. PubMed ID: 9487740
[TBL] [Abstract][Full Text] [Related]
25. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion.
Im SS; Wilczynski SP; Burger RA; Monk BJ
Clin Cancer Res; 2003 Sep; 9(11):4145-50. PubMed ID: 14519638
[TBL] [Abstract][Full Text] [Related]
26. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Oncol; 2002 May; 20(5):1041-7. PubMed ID: 11956602
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
28. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
29. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
Lee JM; Lee KB; Lee SK; Park CY
J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
[TBL] [Abstract][Full Text] [Related]
30. [Detection of HPV DNA presence in lymph nodes as predictive factor in cervical carcinoma patients].
Lukaszuk K; Liss J
Wiad Lek; 2007; 60(7-8):365-70. PubMed ID: 18175557
[TBL] [Abstract][Full Text] [Related]
31. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
32. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
33. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
34. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of HPV infection for cervix cancer].
Girardi F
Ther Umsch; 1989 Dec; 46(12):847-54. PubMed ID: 2560264
[TBL] [Abstract][Full Text] [Related]
36. Detection of HPV DNA in cervical carcinomas by PCR and hybrid capture assay.
Chatterjee R; Mandal B; Bandyopadhyay S
Indian J Pathol Microbiol; 2003 Oct; 46(4):596-9. PubMed ID: 15025352
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
Costa S; Terzano P; Santini D; Ceccarelli C; Martoni A; Angelelli B; Panetta A; Bovicelli A; Cristiani P; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Am J Clin Pathol; 2001 Nov; 116(5):729-37. PubMed ID: 11710691
[TBL] [Abstract][Full Text] [Related]
38. Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage Ia-IIa cervical cancer and their clinical value.
Zhang F; Liu D; Lin B; Hao Y; Zhou D; Qi Y; Zhang S
Oncol Rep; 2012 Jun; 27(6):1801-6. PubMed ID: 22407186
[TBL] [Abstract][Full Text] [Related]
39. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
